, development and industrialization of new drugs that seriously affect the quality of human daily life, including respiratory diseases, and has patent-protected dry powder preparation technology and Efficient and convenient inhaler technology
The tens of billions of diabetes drug market has become a new focus of local drug companies
Time of Update: 2021-10-21
Recently, Huadong Medicine announced that it signed an exclusive product commercialization agreement with multinational pharmaceutical company Takeda (Takeda Pharmaceutical), and obtained the exclusive commercialization of Takeda Pharmaceutical’s innovative product Alogliptin benzoate tablets (trade name: Nisina) in mainland China Equity .
With local pharmaceutical companies investing heavily in innovation, R&D costs have soared
Time of Update: 2021-10-21
For example, as listed biomedical companies on the Sci-tech Innovation Board continued to increase R&D investment in the first half of the year, the total R&D investment amount has reached 5.
Directors, deputy general managers...The wave of resignations of senior executives of listed pharmaceutical companies continues!
Time of Update: 2021-10-21
Kangyuan Pharmaceutical: Director resigns On October 11, Kangyuan Pharmaceutical announced that the company’s board of directors recently received a resignation report from Director, Deputy General Manager, Board Secretary and Chief Financial Officer Yin Honggang.
With the accelerated innovation of pharmaceutical companies, the AI drug research and development track is getting hotter and hotter
Time of Update: 2021-10-21
and development has continued to rise, in order to reduce investment pressure, pharmaceutical companies have begun to use AI platforms to conduct drug research and development cases . Recently, reports have
In order to accelerate innovation and upgrading, this pharmaceutical company has successively introduced a number of innovative drugs
Time of Update: 2021-10-21
In the same year, Huadong Medicine established joint scientific research offices in Boston and Silicon Valley, and publicly stated that it would continue to increase R&D investment and accelerate the development of innovative drugs.
A pharmaceutical company was raided by tax and a multinational pharmaceutical company laid off employees in India
Time of Update: 2021-10-21
According to Indian media reports, last week, the Indian tax authority raided the Hyderabad-based Hetero pharmaceutical company and found unidentified income of up to 5.
A multinational pharmaceutical company continues to deepen its strategic layout in China, and its global R&D China center settles in Shanghai
Time of Update: 2021-10-21
On October 11, AstraZeneca, a multinational pharmaceutical company, officially opened its Global R&D China Center in Shanghai .
8 pharmaceutical companies!
Time of Update: 2021-10-21
>. The company has been profitable for the past three years, and the overall financial situation is sound. Sales revenue and total profit are showing a steady upward trend, and cash flow is sufficient
September Pharmaceutical Events: Corporate Issues: Frequent Major Actions such as Investment and Acquisitions of Listed Companies
Time of Update: 2021-10-21
Jilin Aodong announced on the evening of September 13 that the company has recently received the "Notice of Share Increase Plan" from the controlling shareholder Jincheng Company .
From the field of pharmaceutical equipment to daily chemicals, this pharmaceutical company has taken a "fancy" pace on the road of transformation!
Time of Update: 2021-10-21
to the field of daily chemicals, and its business scope is the sale of toothpaste, soap, synthetic detergent, disinfection products, health care products, oral cleaners, other oral and toothpaste cleaners; self-operating and agency sales of various
Since September, companies in the pharmaceutical industry have been heavily "buy, buy, buy" by institutions
Time of Update: 2021-10-21
4058 million yuan, and a discount rate of 5%; in September, Shengxiang Biotech’s institutional dedicated seats appeared in a total of 8 large transactions.
The AI pharmaceutical track is hot, and another leading pharmaceutical company successfully IPO
Time of Update: 2021-10-21
of 15. 93 million shares were issued at an issue price of US$22 per share and a fund-raising of US$350 million . In addition, Exscientia also simultaneously sold 7. 27 million ADS shares
to be happy for the performance of the sci-tech innovation board drug companies?
Time of Update: 2021-10-21
/> The company's existing products cover infectious disease detection and drug abuse (drug) detection. , Tumor marker detection, myocardial marker detection, and reproductive health detection are five major detection areas, which are widely used
